Skip to main content
EH

Empo Health

Empo Health develops an FDA-listed device and HIPAA-compliant monitoring service for remotely tracking diabetic foot health to prevent ulcers and amputations.

Empo Health, founded in 2020, develops technology for remotely monitoring diabetic foot health. The company aims to prevent complications such as ulcers and amputations, addressing a condition that leads to approximately 150,000 lower-extremity amputations annually in the United States. Its founders were trained at MIT and Stanford.

The company's primary product is the Empo Footprint imaging scale, an FDA-listed device that captures high-resolution images of patients' feet for diabetic neuropathy monitoring. It is paired with the Empo Remote Health Link, a HIPAA-compliant service that automatically transmits these images from patients' homes to their care teams.

In pilot studies, the system reported near-daily patient engagement and detected early ulcer indications in half of participants. The company has secured $15 million in funding and focuses on remote patient monitoring and medical imaging, including image analysis for ulcer detection.

2 Open jobs